Rapid Micro Biosystems signs global distribution deal with Merck KGaA's MilliporeSigma

RAPID MICRO BIOSYSTEMS, INC.

MilliporeSigma gets co-exclusive global rights to sell Growth Direct systems and consumables in pharma, med device, personal care, cosmetics, food & beverage.
MilliporeSigma commits to minimum Growth Direct system purchases in first two years; initial term is five years.
Parties intend to negotiate supply agreement within 6 months and services agreement within 1 year to improve gross margins.
Rapid Micro retains responsibility for installation, validation, and service; existing direct sales and distribution channels continue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.